Entering text into the input field will update the search result below
Search for Symbols, analysts, keywords
CTI BioPharma Corp.
Stock Price & Overview
CTIC is defunct since June 30, 2023.
See All Analysis »
DRI Healthcare Trust says CTI BioPharma repaid $54.8M debt
CTI BioPharma: $1.7bn M&A With 85% Premium, Expect The Deal To Go Through
CTI BioPharma Q1 2023 Earnings Preview
Swedish Orphan Biovitrum Ab to acquire CTI BioPharma for $9.10 per share
VONJO Keeps CTI BioPharma A Buy
Geron, CTI rally after leaked data for Legend Biotech’s blood cancer drug
CTI BioPharma: Q4, Missed Earnings, But Compelling Progress In Market Launch
CTI BioPharma Corp. 2022 Q4 - Results - Earnings Call Presentation
CTI BioPharma Corp. (CTIC) Q4 2022 Earnings Call Transcript
CTI BioPharma GAAP EPS of -$0.14 misses by $0.05, revenue of $21.08M misses by $2.42M
More News And Analysis »
Is this happening to you frequently? Please
report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.